Metabolomic insights into the intricate gut microbial–host interaction in the development of obesity and type 2 diabetes
Year: 2015
Type: review
Abstract: Gut microbiota has recently been proposed as a crucial environmental factor in the development of metabolic diseases such as obesity and type 2 diabetes, mainly due to its contribution in the modulation of several processes including host energy metabolism, gut epithelial permeability, gut peptide hormone secretion, and host inflammatory state. Since the symbiotic interaction between the gut microbiota and the host is essentially reflected in specific metabolic signatures, much expectation is placed on the application of metabolomic approaches to unveil the key mechanisms linking the gut microbiota composition and activity with disease development. The present review aims to summarize the gut microbial-host co-metabolites identified so far by targeted and untargeted metabolomic studies in humans, in association with impaired glucose homeostasis and/or obesity. An alteration of the co-metabolism of bile acids, branched fatty acids, choline, vitamins (i.e., niacin), purines, and phenolic compounds has been associated so far with the obese or diabese phenotype, in respect to healthy controls. Furthermore, anti-diabetic treatments such as metformin and sulfonylurea have been observed to modulate the gut microbiota or at least their metabolic profiles, thereby potentially affecting insulin resistance through indirect mechanisms still unknown. Despite the scarcity of the metabolomic studies currently available on the microbial-host crosstalk, the data-driven results largely confirmed findings independently obtained from in vitro and animal model studies, putting forward the mechanisms underlying the implication of a dysfunctional gut microbiota in the development of metabolic disorders.
Source: Frontiers in Microbiology
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,801
Funders: Joint Programming Initiative A healthy diet for a healthy life, Generalitat de Catalunya, Ministerio de Economía y Competitividad, Junta de Andalucía, Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición, Consejería de Salud y Bienestar Social, Junta de Andalucía, Agència de Gestió d'Ajuts Universitaris i de Recerca, Instituto de Salud Carlos III, European Regional Development Fund, Fundación Pública Andaluza Progreso y Salud, European Social Fund
Awards: G121735339, G1276487608, G2054421916, G2974660153, G3281731996, G4193446334, G4237309756, G5346186829, G6565811481, G812440145, G8515818450, Aplicación de la Metabolómica al estudio de fenotipos discordantes Obesidad/Diabetes. Perfiles metabólicos hacia la prevención y el tratamiento clínico
OpenAlex ID: W1820681798
